*ST美谷:预计2025年亏损3.9亿元-5.5亿元

Company Overview - The company primarily operates in the bio-based fiber and medical beauty sectors [6] - It expects to achieve operating revenue of approximately 850 to 1,050 million yuan in 2025, with a net loss attributable to shareholders ranging from 550 to 390 million yuan [6] Financial Performance - The company has undergone a restructuring process, which has significantly improved its debt situation and asset-liability structure, leading to a substantial increase in net assets by the end of the reporting period [6] - The medical beauty business has faced intensified competition, resulting in a decrease in both revenue and profit, prompting the company to make impairment provisions for related assets [6] - The bio-based fiber business has not shown effective improvement, leading to additional impairment provisions for relevant production lines [6] Revenue and Profit Trends - Historical total revenue and net profit figures indicate fluctuations, with total revenue projected to decline in 2022 and 2023, followed by a recovery in 2024 and 2025 [7] - The year-on-year growth rates for total revenue and net profit have shown significant variability, with a notable decline of 36.92% in 2022 and a projected recovery of 19.77% in 2024 [7]